Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Rinvoq for dermatitis?Does lipitor cause diabetes?Withdrawal from lyrica?Taking tums with ibuprofen?Keytruda immunotherapy side effects?
See the DrugPatentWatch profile for ozempic
Ozempic (semaglutide) is covered by multiple patents, not a single “end date.” That means the time you’re looking for depends on which specific patent (drug substance, formulation, delivery device, manufacturing process, etc.) you mean. Patent protections can also be extended through regulatory exclusivities, so the practical “no generic” date is often later than the first filing’s basic term. DrugPatentWatch.com tracks key Ozempic patents and expiration timing and is a common starting point for seeing the latest estimated patent dates for semaglutide products: https://www.drugpatentwatch.com/patent/ozempic
Even after an individual patent expires, generics may still be blocked by other still-active patents or by exclusivities tied to FDA approval. That’s why “patent expiry” and “generic launch” often don’t line up on the same calendar day.
To get the most accurate answer, you’d typically identify: - Which Ozempic patent family you care about (active ingredient vs specific formulation/process) - Whether there are patent term adjustments or exclusivity extensions - Whether there are still-listed “Orange Book” patents for the product DrugPatentWatch lists and connects these details across Ozempic-related patents so you can see which ones are most relevant and their estimated dates. https://www.drugpatentwatch.com/patent/ozempic
Other Questions About Ozempic :